Literature DB >> 2236009

Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins.

M Shoyab1, V L McDonald, C Byles, G J Todaro, G D Plowman.   

Abstract

Two proteins, termed epithelin 1 and epithelin 2, that inhibit the growth of A431 cells, derived from a human epidermal carcinoma of the vulva, have been purified from rat kidney. Epithelin 1 stimulates the proliferation of murine keratinocytes, whereas epithelin 2 inhibits the epithelin 1-elicited growth of these cells. Thus epithelin 1 and 2 behave as agonist and antagonist, respectively, for normal epithelial cells. Epithelins are low molecular mass (approximately 6 kDa), acid- and heat-stable, single-chain proteins containing approximately 20% cysteine. Some of these cysteines form disulfide linkage(s) that are essential for biological activity. The amino-terminal amino acid sequences of epithelin 1 and epithelin 2 have been determined. The two proteins showed no substantial sequence homology with other proteins. However, a significant homology was seen between the amino-terminal sequences of epithelin 1 and epithelin 2. Epithelins 1 and 2, therefore, appear to represent members of a distinct family of growth regulators.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2236009      PMCID: PMC54861          DOI: 10.1073/pnas.87.20.7912

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines.

Authors:  S D Wolpe; A Cerami
Journal:  FASEB J       Date:  1989-12       Impact factor: 5.191

2.  A biological assay for epidermal growth factor/urogastrone and related polypeptides.

Authors:  G Carpenter; J Zendegui
Journal:  Anal Biochem       Date:  1986-03       Impact factor: 3.365

3.  Two distinct tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.

Authors:  C M Fryling; K K Iwata; P A Johnson; W B Knott; G J Todaro
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

Review 4.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

Review 5.  Growth factors and cancer.

Authors:  A S Goustin; E B Leof; G D Shipley; H L Moses
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

6.  Growth, differentiation and the reversal of malignancy.

Authors:  L Sachs
Journal:  Sci Am       Date:  1986-01       Impact factor: 2.142

7.  Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.

Authors:  K K Iwata; C M Fryling; W B Knott; G J Todaro
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

Review 8.  B cell activation: three steps and their variations.

Authors:  F Melchers; J Andersson
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

9.  Autocrine secretion and malignant transformation of cells.

Authors:  M B Sporn; G J Todaro
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

10.  BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent balb/c mouse epidermal keratinocyte lines.

Authors:  B E Weissman; S A Aaronson
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

View more
  56 in total

Review 1.  Progranulin: a growth factor, a novel TNFR ligand and a drug target.

Authors:  Chuan-ju Liu; Xavier Bosch
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

2.  Structure dissection of zebrafish progranulins identifies a well-folded granulin/epithelin module protein with pro-cell survival activities.

Authors:  Ping Wang; Babykumari Chitramuthu; Andrew Bateman; Hugh P J Bennett; Ping Xu; Feng Ni
Journal:  Protein Sci       Date:  2018-07-18       Impact factor: 6.725

3.  The anti-adipogenic effect of PGRN on porcine preadipocytes involves ERK1,2 mediated PPARγ phosphorylation.

Authors:  Hao Yang; Jia Cheng; Ziyi Song; Xinjian Li; Zhenyu Zhang; Yin Mai; Weijun Pang; Xin'e Shi; Gongshe Yang
Journal:  Mol Biol Rep       Date:  2013-10-05       Impact factor: 2.316

4.  FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology.

Authors:  Qinwen Mao; Xiaojing Zheng; Tamar Gefen; Emily Rogalski; Callen L Spencer; Rosa Rademakers; Angela J Fought; Missia Kohler; Sandra Weintraub; Haibin Xia; Marek-Marsel Mesulam; Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2019-09-01       Impact factor: 3.685

5.  Mapping of Grn, the gene encoding the granulin/epithelin precursor (acrogranin), to mouse chromosome 11.

Authors:  M Bucan; B Gatalica; T Baba; G L Gerton
Journal:  Mamm Genome       Date:  1996-09       Impact factor: 2.957

6.  Progranulin: a novel regulator of gastrointestinal cancer progression.

Authors:  Sharon Demorrow
Journal:  Transl Gastrointest Cancer       Date:  2013-07

Review 7.  Progranulin: A key player in autoimmune diseases.

Authors:  Jinlong Jian; Guangfei Li; Aubryanna Hettinghouse; Chuanju Liu
Journal:  Cytokine       Date:  2016-08-12       Impact factor: 3.861

8.  Inhibition of tumorigenicity of the teratoma PC cell line by transfection with antisense cDNA for PC cell-derived growth factor (PCDGF, epithelin/granulin precursor).

Authors:  H Zhang; G Serrero
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains.

Authors:  V Bhandari; R G Palfree; A Bateman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

10.  Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis.

Authors:  Yasuko Yamamoto; Masao Takemura; Ginette Serrero; Jun Hayashi; Binbin Yue; Aya Tsuboi; Hisako Kubo; Takashi Mitsuhashi; Kenji Mannami; Masao Sato; Hidetoshi Matsunami; Yushi Matuo; Kuniaki Saito
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.